Physician profile
Anthony Lee
NPI 1801060397
$1,111.58
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $195 · 2020: $82.61 · 2021: $135 · 2022: $297 · 2023: $340 · 2024: $61.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $401.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $180.48 | 2021-2023 | Xarelto |
| Teva Pharmaceuticals USA, INC. | $134.33 | 2019-2022 | |
| Celgene Corporation | $73.60 | 2023 | Zeposia |
| Supernus Pharmaceuticals, INC. | $73.11 | 2019-2020 | |
| Abbott Laboratories | $61.90 | 2024 | Amplatzer Talisman |
| Lundbeck LLC | $60.47 | 2023 | Vyepti |
| Sunovion Pharmaceuticals INC. | $53.94 | 2019-2020 | |
| Biogen, INC. | $50.84 | 2019-2022 | |
| Acorda Therapeutics, INC | $46.34 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $44.38 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $39.72 | 2019-2022 | |
| Genentech USA, INC. | $35.90 | 2021-2022 | |
| Ucb, INC. | $35.24 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $29.47 | 2022 | |
| Emd Serono, INC. | $27.95 | 2022-2023 | Mavenclad |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $26.67 | 2022 | |
| Alnylam Pharmaceuticals INC. | $24.77 | 2019 | |
| Sk Life Science, INC. | $20.71 | 2022 | |
| Neurelis, INC. | $20.36 | 2023 | Valtoco |
| Jazz Pharmaceuticals INC. | $19.84 | 2022 | |
| Neurocrine Biosciences, INC. | $19.66 | 2023 | Ingrezza, Ongentys |
| E.R. Squibb & Sons, L.L.C. | $19.42 | 2020 | |
| Acadia Pharmaceuticals INC | $12.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.